A 90-kDa surface glycoprotein was previously isolated and shown to be required for infection by the "major" group of human rhinovirus (IRV) serotypes. In the present work, the amino acid sequence of the receptor protein was obtained from CNBr and tryptic peptides. Using degenerate oligonucleotides predicted from the peptide sequences, we identified four cDNA clones that encode a 3-kilobase mRNA. The clones were ligated, subcloned in a simian virus 40 expression vector, and used to transfect receptor-negative Vero (monkey) cells. Results showed that transfected cells expressed receptor molecules capable of binding HRV and a monoclonal antibody which recognizes the mjor group HRV receptor. The cloned receptor cDNA encoded a protein with a sequence nearly identical to that of the intercellular adhesion molecule 1 (ICAM-1), indicating that the two surface proteins are one and the same. Both proteins have identical mass, carbohydrate composition, and tissue distribution. In addition, major group receptors on HeLa cells could be induced with various cytokines in a manner similar to the ICAM-1 ligand. A similar induction of the HRV "minor" group receptor was not observed.
erate oligonucleotides predicted from the peptide sequences, we identified four cDNA clones that encode a 3-kilobase mRNA. The clones were ligated, subcloned in a simian virus 40 expression vector, and used to transfect receptor-negative Vero (monkey) cells. Results showed that transfected cells expressed receptor molecules capable of binding HRV and a monoclonal antibody which recognizes the mjor group HRV receptor. The cloned receptor cDNA encoded a protein with a sequence nearly identical to that of the intercellular adhesion molecule 1 (ICAM-1), indicating that the two surface proteins are one and the same. Both proteins have identical mass, carbohydrate composition, and tissue distribution. In addition, major group receptors on HeLa cells could be induced with various cytokines in a manner similar to the ICAM-1 ligand. A similar induction of the HRV "minor" group receptor was not observed.
Human rhinoviruses (HRVs) are members of the Picornaviridae and are the major causative agent of the common cold in humans (1) . Earlier studies have indicated that HRV serotypes can be divided into "major" (78 serotypes) and "minor" (10 serotypes) groups based on receptor specificity (2, 3) . An anti-receptor monoclonal antibody (designated antibody 1A6) has been previously isolated which specifically blocks attachment of the major group of HRVs (4) . By using this antibody, a 90-kDa glycoprotein was isolated from HeLa cell membranes and shown to be required for attachment of the major group of HRVs to susceptible cells in culture (5) . Chimpanzee and human clinical trials testing the efficacy of antibody 1A6 have also demonstrated that this receptor is involved in HRV infection of the nasal cavity in vivo (6, 7) . Further biochemical characterization of the purified 90-kDa protein demonstrated that it was an acidic glycoprotein having a pI of4.2 (8) . Carbohydrates accounted for 30% ofthe molecular mass of the protein and seven N-glycosylation sites were predicted on the basis of partial digestion with N-Glycanase (8) .
The intercellular adhesion molecule 1 (ICAM-1) is a cell surface ligand for the lymphocyte function-associated antigen 1 (LFA-1) adhesion receptor (9) . ICAM-1 is a singlechain 76-to 114-kDa glycoprotein with a polypeptide core of 55 kDa that can be induced by several cytokines (10) . The interaction of ICAM-1 and LFA-1 plays an important role in leukocyte adhesion and in the execution of immunological and inflammatory functions (10) .
The present study describes the cloning and sequencing of the cDNA that encodes the cell surface receptor required for infection by the major group ofHRVs.t Sequence and protein comparisons show that ICAM-1 is the surface glycoprotein utilized by HRVs during infection.
MATERIALS AND METHODS
Peptide Sequence. HRV major group receptor protein was isolated from HeLa R19 cells (2) and purified by immunoaffinity chromatography as previously described (5) . Purified protein (40 ug) was reduced in 6 M guanidine hydrochloride/0.1 M Tris'HCl, pH 7.1/0.1% EDTA containing 100 mM dithiothreitol at 500C for 2.5 hr, then alkylated with 0.5 ,uM iodoacetic acid in the same buffer at pH 7.8 for 45 min at 230C. After extensive dialysis against H20, the protein was lyoph' ilized and treated with 0.4 mM CNBr in 70% (vol/vol) formic acid at 230C for 20 hr. The sample was chromatographed on a 10%o polyacrylamide gel and transferred onto Polybrenecoated glass fiber filters (11) . Strips containing peptides were cut out and the N-terminal sequence was determined as described (12) .
Alternatively, 80 1Lg of receptor protein was purified by PAGE and transferred directly onto a nitrocellulose filter. Filter strips were blocked and then digested with 1.2 ug of tosylamido-2-phenylethyl chloromethyl ketone-treated trypsin for 18 hr at 370C (13) . The resulting peptides were separated by reverse-phase HPLC and sequenced as above.
Preparation and Screening of cDNA Libraries. Polysomal mRNA and total RNA were isolated from dividing HeLa R19 cells by using the procedures detailed previously (14, 15 The four clones were ligated (Fig. 2) as described in further characterized. Of these, only one clone (20C) was Materials and Methods and the complete sequence was hybridization positive with more than one probe. In fact, determined by dideoxy sequencing (Fig. 3) ACCTATCCCG GGACAGGGCC TCTTCCTCGG CCTTCCCATA TTGGTGGCAG TGGTGCCACA CTGAACAGAG TGGAAGACAT ATGCCATGCA GCTACACCTA CCGGCCCTGG (1780) GACGCCGGAG GACAGGGCAT TGTCCTCAGT CAGATACAAC AGCATTTGGG GCCATGGTAC CTGCACACCT AAAACACTAG GCCACGCATC TGATCTGTAG TCACATGACT (1890) AAGCCAAGAG GAAGGAGCAA GACTCAAGAC ATGATTGATG GATGTTAAAG TCTAGCCTGA TGAGAGGGGA AGTGGTGGGG GAGACATAGC CCCACCATGA GGACATACAA (2000) CTGGGAAATA CTGAAACTTG CTGCCTATTG GGTATGCTGA GGCCCCACAG ACTTACAGAA GAAGTGGCCC TCCATAGACA TGTGTAGCAT CAAAACACAA AGGCCCACAC (2110) TTCCTGACGG ATGCCAGCTT GGGCACTGCT GTCTACTGAC CCCAACCCTT GATGATATGT ATTTATTCAT TTGTTATTTT ACCAGCTATT TATTGAGTGT CTTTTATGTA (2220) GGCTAAATGA ACATAGGTCT CTGGCCTCAC GGAGCTCCCA GTCCATGTCA CATTCAAGGT CACCAGGTAC AGTTGTACAG GTTGTACACT GCAGGAGAGT GCCTGGCAAA (2330) AAGATCAAAT GGGGCTGGGA CTTCTCATTG GCCAACCTGC CTTTCCCCAG AAGGAGTGAT TTTTCTATCG GCACAAAAGC ACTATATGGA CTGGTAATGG TTCACAGGTT (2440) CAGAGATTAC CCAGTGAGGC CTTATTCCTC CCTTCCCCCC AAAACTGACA CCTTTGTTAG CCACCTCCCC ACCCACATAC ATTTCTGCCA GTGTTCACAA TGACACTCAG (2550) CGGTCATGTC TGGACATGAG TGCCCAGGGA ATATGCCCAA GCTATGCCTT GTCCTCTTGT CCTGTTTGCA TTTCACTGGG AGCTTGCACT ATTGCAGCTC CAGTTTCCTG (2660) CAGTGATCAG GGTCCTGCAA GCAGTGGGGA AGGGGGCCAA GGTATTGGAG GACTCCCTCC CAGCTTTGGA AGCCTCATCC GCGTGTGTGT GTGTGTGTGT ATGTGTAGAC (2770) AAGCTCTCGC TOTGTGAOOO AGGOTGGAGT GCAGTGGTGC AATOATGGTT GACTGOAGTO TTGAOOTTTT GGGOTCAAGT GATOOTOOGA OOTGAGOOTO OTGAGTAGOT (2880) GGGACCATAG GCTCACAACA CCACACCTGG CAAATTTGAT TTTTTTTTTT coding 532 amino acids if the first ATG was utilized. This would indicate a 71-nucleotide 5' noncoding region and a 1333-nucleotide 3' noncoding region, excluding the poly(A) tail. No additional long open reading frames could be found in the 3' noncoding region, suggesting that the stop codon at position 1668 is the site for termination of protein synthesis. This was verified by in vitro translation of RNA derived from pHRVrl, which resulted in a single polypeptide of 55 kDa (data not shown) that is in close agreement to the 54-to 60-kDa size found for deglycosylated receptor protein (8) .
The location of each of the peptide sequences is shown in Fig. 3 . Placement of the C1 peptide within the sequence indicated that a methionine does not exist in close proximity to the cleavage site and that cleavage apparently occurred at a tryptophan residue as a result of oxidation during isolation or chemical cleavage procedures. This type of cleavage has been reported previously (21) .
Transfection with HRV Receptor Gene cDNA. To demonstrate that the cloned HRV receptor sequence did indeed encode the receptor protein of major group HRVs, a DNA insert representing nucleotides 48-2988 was subcloned in a simian virus 40 transfection vector and used to transfect a HRV receptor-minus cell line (Vero). After a 48-hr incubation, specific binding of radiolabeled antibody 1A6 and HRV-15 was observed in pSVL-HRVrl-transfected Vero cells (Table 2) . No specific binding could be demonstrated with nontransfected cells.
Homology to ICAM-1 Sequence. The sequence predicted for the 90-kDa HRV cell receptor from HeLa cells displayed striking homology to the sequence obtained for the ICAM-1 gene obtained from cytokine-induced HL-60 cells (22, 23) . Direct comparison of the sequences revealed only six nucleotide differences. The HRV receptor gene had a G-to-A substitution at nucleotide 1476 that resulted in a Glu-to-Lys amino acid change at residue 442, a GG-to-CC substitution at nucleotides 2733-2734, and insertion ofa C at nucleotide 2043 and a GT at nucleotide 2743. Review of the protein characteristics of the 90-kDa HRV receptor and the ICAM-1 ligand molecule shows that both are surface proteins of similar molecular weight, are ubiquitous among human-derived cells, and have an equivalent number of glycosylation sites (8, 22, 23 cells was low compared to that observed in hematopoietic cells but clearly indicates that the HRV receptor is inducible by cytokines.
It has been previously postulated that the receptor molecules used by the major and minor groups of HRVs, polioviruses, and coxsackie B viruses may share some structural homology (24) . As a preliminary experiment to ascertain whether the minor group HRV receptor is another adhesion molecule that can also be induced by cytokines, HeLa cells were induced as described above and assayed for their ability to bind the minor group virus HRV-2. As shown in Fig. 4B 5, 8, 10, 23) . Amino acids -27 to -1 and 454 to 477 represent putative signal and transmembrane sequences of ICAM-1, respectively ( Fig. 3; ref. 23 ). Several nucleotide differences were found between the two sequences in the 3' noncoding region and one change occurred in the coding region, replacing a Glu residue by a Lys residue. An additional 14 bases were identified at the 5' end of the HRV receptor cDNA that were not reported in the ICAM-1 sequence (22, 23) . Our clone may not represent the entire 5' end of the mRNA, since Northern blot analysis indicated that the ICAM-1 mRNA is 3.2-3.3 kb in length (22, 23) .
ICAM-1 is a cell surface ligand for LFA-1, and the interaction between these molecules plays an important role in several immunological and inflammatory functions mediated by leukocyte adhesion (10) . This cellular adhesion pathway is one of at least three mechanisms utilized (10) . The ICAM-1 ligand is a member of the immunoglobulin gene superfamily and is predicted to have five homologous immunoglobulinlike domains defined by amino acids 1-88, 89-185, 186-284, 285-385, and 386-453 (Fig. 2) (23) . In addition, ICAM-1 is closely related to two adhesion proteins of the adult nervous system, namely neural cell adhesion molecule (NCAM) and myelin-associated glycoprotein (MAG) (22, 23) .
Both the ICAM-1 and HRV receptor molecules have been shown to be ubiquitous on human-derived cells (4, 10) and clearly cannot account for the observed restriction of HRVs to the nasal cavity during a common cold. The significance of HRVs utilizing receptors having immunological and inflammatory functions is unclear. It has been reported that HRV infection involves a very limited number of cells in the nasal epithelium and that the clinical symptomatology that we associate with a cold may instead result from the generation of inflammatory mediators such as kinins (25) . It is tempting to speculate that virus interaction with ICAM-1 somehow plays an important role in the production of kinins, other mediators, or both.
Recent mutagenic studies using an infectious DNA clone of HRV-14 have demonstrated that the deepest regions of the virion canyon structure are involved in receptor interaction (24) . The finding that this region of the canyon is highly conserved among a number of picornaviruses belonging to different receptor families led to the supposition that the receptor molecules that interact with these different viruses have a structural binding domain in common (24) . It was further suggested that the specificity of the receptor protein utilized for attachment was determined by the rim of the canyon, since this region of the capsid was highly variable and thus would define the structural requirements of receptor interaction with the virus.
Support for this hypothesis may be found in the recent cloning and sequencing of the poliovirus receptor gene (26) . The poliovirus receptor molecule also appears to be a member of the immunoglobulin gene superfamily, and has three homologous immunoglobulin-like domains and some sequence homology to neural cell adhesion molecule. It is very likely that receptor genes for the HRV minor group and coxsackie B viruses also will be members of the immunoglobulin gene superfamily. It is interesting to note that, unlike the major group receptors, none of the other picornavirus receptors tested could be induced in HeLa cells by cytokine treatment and that the basal level ofthe minor group receptor on HeLa cells is almost equal to the cytokine-induced level of the major group (Fig. 4 and unpublished data) .
Formerly, viral receptor studies were restricted to biochemical and biological characterization. The availability of receptor gene clones should greatly facilitate our studies of virus-receptor interactions by providing a means to map binding domains via mutagenesis.
